Entresto 49 MG-51 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F5ZNU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,985
Award facts
- Contract value 100% obligated
- $49,985.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a ceiling value of $49,985.02. This is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, to be performed at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA and its Medical Supply Chain, covering diverse therapeutic domains including pain management, neurological treatments, diabetes medications, and specialized medical supplies. This contract exemplifies AmerisourceBergen's role as a key supplier in the Defense Health Agency's pharmaceutical supply chain, delivering essential medications to support military treatment facilities and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5ZNU?
SPE2DR26F5ZNU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F5ZNU worth?
The government has obligated $49,985 on SPE2DR26F5ZNU.
Is contract SPE2DR26F5ZNU an order under another contract?
Yes. SPE2DR26F5ZNU is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZNU competed?
The extent of competition for SPE2DR26F5ZNU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award